Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7. (Q50993571)

26 March 2018

title

Bone morphogenetic proteins inhibit CD40L/IL-21-induced Ig production in human B cells: differential effects of BMP-6 and BMP-7. (English)

1 reference

26 March 2018

1 reference

7

Erlend B Smeland

1 reference

26 March 2018

8

June H Myklebust

1 reference

26 March 2018

Kanutte Huse

1

object named as

Kanutte Huse

1 reference

26 March 2018

Morten P Oksvold

3

object named as

Morten P Oksvold

1 reference

26 March 2018

author name string

Maren Bakkebø

2

1 reference

26 March 2018

Lise Forfang

4

1 reference

26 March 2018

Vera I Hilden

5

1 reference

26 March 2018

Trond Stokke

6

1 reference

26 March 2018

language of work or name

English

0 references

publication date

18 October 2011

1 reference

26 March 2018

European Journal of Immunology

published in

1 reference

26 March 2018

volume

41

1 reference

26 March 2018

issue

11

1 reference

26 March 2018

page(s)

3135-3145

1 reference

26 March 2018

Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Regulation of plasma-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

The balance between Pax5 and Id2 activities is the key to AID gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Plasma cell differentiation requires the transcription factor XBP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Blimp-1 Is Required for the Formation of Immunoglobulin Secreting Plasma Cells and Pre-Plasma Memory B Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Interferon regulatory factor 4 and 8 in B-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Signal transduction of bone morphogenetic protein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Id: a target of BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Bone morphogenetic protein receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

CpG drives human transitional B cells to terminal differentiation and production of natural antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Transforming growth factor type beta (TGF beta) inhibits G1 to S transition, but not activation of human B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

BMP-2/4 and BMP-6/7 differentially utilize cell surface receptors to induce osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

E-proteins directly regulate expression of activation-induced deaminase in mature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Requirement for Runx proteins in IgA class switching acting downstream of TGF-beta 1 and retinoic acid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

A new method for detachment of Dynabeads from positively selected B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

7 January 2021

Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

7 January 2021

Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

7 January 2021

Lineage-restricted expression of bone morphogenetic protein genes in human hematopoietic cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

7 January 2021

Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201141558

7 January 2021

Identifiers

DOI

10.1002/EJI.201141558

1 reference

26 March 2018

PubMed ID

21898381

1 reference

26 March 2018